DVL3 and cancer: Ali et al[53] discovered that using butyrate and knocking out DVL3 could significantly reduce the proliferation of cancer cells by cell transfection experiments, suggesting that the anti-cancer molecule butyrate inhibited the Wnt signaling pathway and resisted COAD by inhibiting DVL3.